Drug Shortage Report for GLN-ATOVAQUONE
| Report ID | 236216 |
| Drug Identification Number | 02528495 |
| Brand name | GLN-ATOVAQUONE |
| Common or Proper name | Mepron |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ATOVAQUONE |
| Strength(s) | 750MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 210 ml Bottle |
| ATC code | P01AX |
| ATC description | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2024-08-29 |
| Actual start date | 2024-08-29 |
| Estimated end date | 2024-10-09 |
| Actual end date | 2024-10-16 |
| Shortage status | Resolved |
| Updated date | 2024-10-17 |
| Company comments | RESOLVED |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2024-10-17 | English | Compare |
| v11 | 2024-10-16 | French | Compare |
| v10 | 2024-10-16 | English | Compare |
| v9 | 2024-09-27 | French | Compare |
| v8 | 2024-09-27 | English | Compare |
| v7 | 2024-09-27 | French | Compare |
| v6 | 2024-09-27 | English | Compare |
| v5 | 2024-09-26 | French | Compare |
| v4 | 2024-09-26 | English | Compare |
| v3 | 2024-08-30 | English | Compare |
| v2 | 2024-08-29 | French | Compare |
| v1 | 2024-08-29 | English | Compare |
Showing 1 to 12 of 12